Reuters file image of Remdesivir used for representation
MUMBAI/NEW DELHI: Import consignments of crucial raw materials stuck at ports and airports will impact production of key Covid-19 drugs, Remdesivir and Favipiravir, as well as other life-saving medicines, leading to potential shortages across the country.
Besides, shipments of even critical medical devices such as infrared thermometers and pulse oximeters are also affected.
The delay in clearance of consignments of key chemicals used to produce advanced pharmaceutical ingredients (APIs) and formulations for lifesaving Covid-19 drugs, will impact the drugs’ production schedule, which is critical in the present scenario. Mylan, one of the six manufacturers of Remdesivir, a drug granted “emergency use” approval by US Food and Drug Administration for treatment of severely-ill Covid-19 patients, said the delay and hold up will impact the availability of drugs.
This is even as the health ministry and Pharmexcil have sought early clearance of consignments.